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The International League Against Epilepsy (ILAE) is an important source of guidance for 
health professionals when it comes to epilepsy. Their latest recommendation that epi-
lepsy should no longer be called a “disorder,” but a “disease” has though caused contro-
versy. The ILAE contends the change will improve epilepsy’s image. Some clinicians and 
other organizations fear the change may not though be accepted by patients as in com-
mon parlance “disease” can be associated with “contagiousness”/”infection.” To allow 
practicing clinicians to make informed judgements about what language they use, we 
completed the first study to assess the preferences of those with epilepsy and significant 
others and explore if any of their characteristics were associated with preference. Via 
epilepsy interest groups and associations in England, Wales, Scotland and the Republic 
of Ireland, 971 patients and significant others were surveyed. Participants identified 
which of four labels for epilepsy (“disorder,” “illness,” “disease,” “condition”) they fa-
voured and rated each using a Likert- scale. Patients’ median age was 39; 69% had expe-
rienced seizures in the prior year. “Condition” was favoured by most patients (74.3%) and 
significant others (71.2%). Only 2.2% of patients and 1.2% of significant others chose 
“disease”; it received a median Likert- rating indicating “strongly dislike.” Multinomial lo-
gistic regression found it was not possible to reliably distinguish between participants 
favouring the different terms on the basis of demographics. The ILAE’s position is at odds 
with what most patients and carers want and we discuss the implications of this.
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1  | INTRODUCTION
The International League Against Epilepsy (ILAE) is an important 
source of guidance when it comes to epilepsy.1 Their recently pub-
lished revised, operational definition of epilepsy 2 is therefore note-
worthy. A key change is that epilepsy is no longer a “disorder,” rather it 
is now to be labelled a “disease.” This is intended to improve epilepsy’s 
profile. “Disorder,” they said, was “poorly understood by the public and 
implied a functional, temporary disturbance and so minimised the se-
riousness of epilepsy” (p.476).2 “Disease” was felt to hold more gravity 
and thus better communicate epilepsy’s life implications.3
Epilepsy’s profile within the public domain does need improv-
ing. Attitudes towards epilepsy are often negative and it attracts 
less attention than its prevalence and impact warrant.4,5 There is no 
evidence that calling epilepsy a disease will address this. Marketing 
experts have though recommended it: “[Y]ou cannot arouse pub-
lic passion about a ‘disorder’, you have to call epilepsy a ‘disease’”6 
(p.2363).
Some though, have advised against the change.7,8 When the ILAE’s 
draft went for consultation, 113 comments relating to the change 
were submitted.7 Health professionals were concerned it would not be 
supported by patients and carers. They said “disease” remains poorly 
defined and, within common parlance, is often associated with ideas 
of “contagiousness” and “infectiousness.”7 It was also contended the 
label may have ramifications for how someone accepts a new diagno-
sis and views themselves.
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Whilst the label change is clearly contentious amongst health pro-
fessionals, it is not actually known how patients and carers view it. 
Their preferences have not been systematically examined. To allow 
clinicians and others to make informed decisions about the language 
they adopt when discussing epilepsy, we asked a large sample of 
persons living with epilepsy and significant others about label pref-
erences. We also tested which, if any, of their characteristics were as-
sociated with their preference.
2  | METHODS
2.1 | Participants
Persons with epilepsy and significant others (i.e., friends, family, in-
formal carers). All were aged ≥18years. Patients were those self-
reporting a clinical diagnosis of epilepsy (any syndromes/seizure type). 
People were excluded if they could not provide informed consent or 
were unable to independently complete English questionnaires.
2.2 | Procedure
Between December 2015 and February 2016, an online survey was 
conducted. It was designed to address wider questions regarding per-
ceptions of stigma.9,10 Participants were recruited by advertisements 
in the newsletters and websites of epilepsy interest groups and organ-
izations within England, Scotland, Wales and the Republic of Ireland. 
People wishing to take part were directed to an online survey page.
The University of Liverpool’s Institute of Psychology Health and 
Society Research Ethics Committee approved the study (IPHS- 1516- 
SMc- 105). Informed consent was obtained from all.
2.3 | Measures
2.3.1 | Characteristics
Participants reported their demographics and medical history. Table 1 
details the information asked for.
2.3.2 | Preference
Participants were presented with the following: “People use different 
terms/expressions to describe what epilepsy is. For example, some 
people call epilepsy a ‘condition’, whereas others call it an ‘illness’. 
Below are some sentences that use different terms.” They then saw 
four different phrases: “Epilepsy is an illness,” “Epilepsy is a condition,” 
“Epilepsy is a disease,” and “Epilepsy is a disorder.” Participants identi-
fied which one term they preferred and rated the extent to which they 
liked each using a Likert- scale (1=“strongly dislike,” 5=“strongly like”).
2.4 | Analysis
Descriptive statistics were produced using STATA 11 (Stata 
Corporation, College Station, TX, USA). Proportions with 95% 
confidence intervals (95% CI) and medians, along with the interquar-
tile range (IQR) are reported to describe participants’ preferences. 
Patients’ and significant others’ preferences were analysed separately.
Multinomial logistic regression, with robust standard errors, ex-
plored whether any of the participants’ characteristics were associated 
with label preference. Only a small number of participants ultimately 
selected “disease” and its inclusion in predictive modelling would 
have made the resulting models unstable. It was therefore excluded 
and regression completed with marginally smaller samples to deter-
mine how participant characteristics were associated with preference 
for any of the three remaining labels. Unadjusted regression was first 
completed. Any significantly associated (P<.05) variables were then 
simultaneously entered into adjusted regression analyses to identify 
parsimonious predictors. Where a cell of a categorical independent 
variable contained fewer than five participants, the characteristic was 
not examined (see notes to Tables S1 and S2). Relative risk ratios (RRR) 
along with 95% CIs describe associations. To determine how well the 
final models predicted preference, area under the curve (AUC) statis-
tics were estimated using the “mlogitroc” command, which generates 
multiclass ROC curves for classification accuracy using bootstrapping 
methods and smoothed probability distributions derived from kernel 
density estimation.11An AUC of 0.5 represents random prediction, 
whilst an AUC of 1 represents perfect prediction.
3  | RESULTS
3.1 | Participant characteristics
One thousand and eighty- two participants were recruited (695 pa-
tients and 387 significant others). Of these, 89.7%, n=971 (638 pa-
tients and 333 significant others) had complete preference data and 
were included in analyses (Table 1).
There were no statistical differences between patients with and 
without complete data in age, sex or ethnicity (all P>.05). Significant 
others with and without missing data also did not differ from one an-
other in age or ethnicity. Males were though, more likely to have miss-
ing data (23.9% vs 12.6%; P=.03).
Patients’ median age was 39 (IQR=28- 49.25), and 76.6% were fe-
male. Median years since diagnosis was 16 (IQR=7- 28). Most (69.1%) 
had experienced a seizure within the prior year. Median age of signifi-
cant others was 46 (IQR=39- 55), and most were female (89.5%). Most 
(70.3%) were a parent to someone with epilepsy.
3.2 | Preference
Most patients (n=474; 74.3%; 95% CI: 70.9- 77.7) and significant 
others (n=237; 71.2%; 95% CI: 66.3- 76.1) chose “condition” as the 
term they favoured (Table 2). The median rating it received from pa-
tients and significant others on the preference scale was 4, equating 
to “Like.”
Only 14 (2.2%, 95% CI: 1.1- 3.3) patients and 4 (1.2%, 95% CI: 0.0- 
2.3) significant others chose “disease” as their favoured term. The me-
dian preference rating given to it was 1, indicating “strongly dislike.”
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3.3 | Characteristics associated with label 
most favoured
In unadjusted analyses years diagnosed with epilepsy, the presence 
of comorbidity, employment status and sex were significantly associ-
ated with patients preference (Table S1). When entered into an ad-
justed model, only the presence of a comorbidity and sex remained 
significant. Those with a comorbidity (n=36, 19.1%) were twice as 
likely to favour “illness” over “condition” than those without one 
(n=54, 10.4%; adjusted RRR=2.03, 95% CI: 1.26, 3.28), whilst females 
(n=39, 8.2%) were less likely to favour “condition” over “disorder” 
than males (n=21, 14.3%; adjusted RRR=0.52, 95% CI: 0.29, 0.92). 
The AUC statistic for this final model was 0.56, indicating poor over-
all predictive ability.
TABLE  1 Participant characteristics
Patients (N=638)
Family and 
friends (N=333)
Age
Median (IQR) 39 (28- 49.25) 46 (39- 55)
20- 31 y 198 (31.0) 46 (13.8)
32- 42 y 168 (26.3) 80 (24.0)
43- 51 y 142 (22.3) 98 (29.4)
52- 81 y 130 (20.4) 109 (32.7)
Sex (n/%)
Female 489 (76.6) 298 (89.5)
Male 149 (23.4) 35 (10.5)
Ethnicity (n/%)
White British 604 (94.7) 319 (95.8)
Other 34 (5.3) 14 (4.2)
Main spoken language
English 626 (98.1) 327 (98.2)
Other 12 (1.9) 6 (1.8)
Confidence in English if not first language
 “Very well” 5 (41.7) 5 (83.3)
 “Well” 7 (58.3) 1 (16.7)
 “Not well” 0 (0.0) 0 (0.0)
 “Not at all” 0 (0.0) 0 (0.0)
Highest educational attainment (n/%)
Basic school certificate or 
lower
169 (26.5) 85 (25.5)
Advanced school 
certificate or equivalent
142 (22.3) 66 (19.8)
University degree, 
Diploma or higher
327 (51.3) 182 (54.7)
Employment (n/%)
Employed (full/
part- time)/student
389 (61.0) 217 (65.2)
Homemaker/Other 172 (27.) 108 (32.4)
Unemployed 77 (12.1) 8 (2.4)
Main epilepsy doctor (n/%)
Primary care 142 (22.3) - 
Hospital specialist 371 (58.2)
Equally shared between 
primary care and 
specialist
125 (19.6)
Age at diagnosis
Median (IQR) 18 (12- 27) - 
Years diagnosed
Median (IQR) 16 (7- 28) - 
Anti- epileptic medication (n/%)
None 28 (4.4) - 
Monotherapy 272 (42.6)
Polytherapy 338 (53.)
(Continues)
Patients (N=638)
Family and 
friends (N=333)
Seizures (any type) prior 12 moa (n/%)
Yes 441 (69.1) - 
No 197 (30.9)
Median (IQR) 5.0 (0- 10)
Experience convulsive seizures? (n/%)
Yes 478 (74.9) - 
No 160 (25.1)
Nocturnal seizures only? (n/%)
No 546 (85.6) - 
Yes 92 (14.4)
Reported cause of epilepsy
Unknown 429 (67.2) - 
Acquired brain injury 90 (14.1)
Other 119 (18.7)
Medical history (beyond epilepsy; n/%)
None 356 (55.8) - 
Another medical 
diagnosis
202 (31.7)
Psychiatric diagnosis 32 (5.0)
Both medical and 
psychiatric diagnoses
45 (7.5)
Relationship to patient.
Spouse/partner - 40 (12.0)
Parent 234 (70.3)
Friend 24 (7.2)
Child 11 (3.3)
Otherb 24 (7.2)
IQR, interquartile range; n,number; SD, standard deviation.
aThapar et al.’s scale asks “How many attacks have you had in the last 
12 mo?” The participant can choose from the following ordinal categories: 
0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more.
bOther category includes siblings, cousins, aunts and uncles.
TABLE  1  (Continued)
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For significant others, their age, employment status and the num-
ber of seizures they estimated the person they knew to have experi-
enced in the prior year were significantly associated with preference 
in unadjusted analyses (Table S2). In adjusted analyses, being currently 
employed or in education was associated with being more likely to 
prefer “disorder” over “condition” (adjusted RRR=2.37, 95% CI: 1.15, 
4.86), as was an increase in seizures (adjusted RRR=1.12, 95% CI: 1.02, 
1.24).) Again, the AUC statistic for this model, 0.50, indicated poor 
overall predictive ability.
4  | DISCUSSION
4.1 | Patient and carer preference
Our results indicate most patients and informal carers do not want 
epilepsy to be labelled a “disease” —9/10 are against it. “Condition” is 
instead favoured. This new evidence can be used by neurologists and 
others to help them decide what language to adopt.
To minimize participant burden, we did not ask participants’ the 
reasons for their preference. We did complete regression analyses to 
explore if preference was associated with the patient’s or significant 
other’s characteristic to see whether this could offer any insights. A 
handful of variables were associated with preference. Overall, how-
ever, the ability to use this information to reliably predict preference 
was limited. This suggests additional factors beyond those which we 
examined are important in determining preference. It might therefore 
be most helpful to consider the results of the current survey in the 
context of reasons given by persons with epilepsy in online forums as 
to why they object to the label “disease.”12 Patients there appear con-
cerned that within lay use, “disease” is associated with “infectiousness” 
and that this could contribute to misconceptions. Indeed, this appears 
why no patient- led epilepsy organization operating in an English 
speaking country has adopted the ILAE’s new stance (Table S3.).
Whether “disease” does evoke more ideas of “contagiousness” in 
the minds of the public is not known. There are diagnoses where it 
does not appear to (e.g., coronary heart disease, Alzheimer’s). However, 
might it in the context of epilepsy? If so, this would be concerning as 
older ideas about epilepsy remain and so terms reinforcing them need 
avoiding. Austin et al.13 found only half of American adolescents were 
confident epilepsy was not contagious.
4.2 | Implications
The ILAE’s Task Force acknowledged their definition was informed 
by available evidence. At the time, none existed on patients or carers’ 
preferences. Now it is, should their position change?
It could be reasoned that it should not. It was done with the admi-
rable goal of improving epilepsy’s image. If it ultimately does this, the 
change, however unpopular, would be justified. On the other hand, 
the ILAE themselves2 stated “A definition should conform to how cli-
nicians and patients think…” (p.476). It appears the “disease” element 
of their revised definition does not align with what most patients or 
carers (and many clinicians) think. This could become a source of ten-
sion between the ILAE and those it seeks to support. One patient has 
already publically noted7:
It [epilepsy] is not contagious, although there are some 
who still believe it is. They think I have a disease, and avoid 
me so as not to catch it. Now some of the most eminent 
epileptologists on the planet are telling me that those ig-
norant and bigoted people are correct. Does this mean it’s 
time for another identity crisis?
4.2.1 | Strengths and weaknesses
Strengths include that recruitment happened across multiple coun-
tries. Our large sample means study estimates also have narrow CIs.
Potential weaknesses are that our participants were recruited 
via newsletters from epilepsy organizations and interest groups. Not 
all people receive such correspondence and the views of these per-
sons might differ from those who do. Our patients were also slightly 
younger and more educated than those in the wider epilepsy popu-
lation. This likely occurred because participation was online; 86% of 
UK households have Internet access, but age and cost are barriers.14
Our findings may have international relevance as the study fo-
cused on English phrases. English is the third most widely first- spoken 
language15 and the language of science. Our study does not, how-
ever, indicate what the preferences are of people when another lan-
guage is used. Some of the phrases we presented to our participants 
do not have equivalents in some languages and even when they can 
be directly translated, it is unclear whether the terms have the same 
TABLE  2 Preferred terms and ratings for what epilepsy should be labelled as
Term
Patients (N=638) Significant others (N=333)
Most favoured term Preference rating Most favoured term Preference rating
n (%) 95% CI Median (IQR) n (%) 95% CI Median (IQR)
Epilepsy is an condition 474 (74.3) 70.9- 77.7 4 (4- 5) 237 (71.2) 66.3- 76.1 4 (4- 4)
Epilepsy is an illness 90 (14.1) 11.4- 16.8 2 (1- 3) 50 (15.0) 11.2- 18.9 3 (2- 3)
Epilepsy is a disorder 60 (9.4) 7.1- 11.7 3 (1- 3) 42 (12.6) 9.0- 16.2 3 (2- 4)
Epilepsy is a disease 14 (2.2) 1.1- 3.3 1 (1- 2) 4 (1.2) 0.0- 2.3 1 (1- 2)
IQR, interquartile range; CI, confidence interval; Higher scores on preference rating scale reflect greater preference (1=“strongly dislike,” 2=“dislike,” 
3=“neither like or dislike,” 4=“like,” 5=“strongly like”).
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connotations as the English phrases that those with epilepsy and their 
carers appear concerned about.
5  | CONCLUSION
Findings suggest the ILAE needs to better communicate its reasons 
for calling epilepsy a “disease” or reverse its decision. At present, la-
belling epilepsy a “disease” is at odds with what most patients and 
carers want.
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